Boris Yagen

3.6k total citations
117 papers, 3.0k citations indexed

About

Boris Yagen is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Boris Yagen has authored 117 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pediatrics, Perinatology and Child Health, 46 papers in Psychiatry and Mental health and 31 papers in Molecular Biology. Recurrent topics in Boris Yagen's work include Pharmacological Effects and Toxicity Studies (54 papers), Epilepsy research and treatment (45 papers) and Mycotoxins in Agriculture and Food (17 papers). Boris Yagen is often cited by papers focused on Pharmacological Effects and Toxicity Studies (54 papers), Epilepsy research and treatment (45 papers) and Mycotoxins in Agriculture and Food (17 papers). Boris Yagen collaborates with scholars based in Israel, United States and Germany. Boris Yagen's co-authors include Meir Bialer, Abraham Rubinstein, Irit Gliko-Kabir, Nina Isoherranen, Jakob A. Shimshoni, Richard H. Finnell, Adel Penhasi, Bogdan J. Wlodarczyk, Volker Schurig and Sara Eyal and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Boris Yagen

115 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Yagen Israel 32 956 904 829 547 340 117 3.0k
Jeffrey Grove France 37 359 0.4× 3.4k 3.8× 347 0.4× 246 0.4× 579 1.7× 93 5.6k
Fátima Martel Portugal 37 617 0.6× 1.6k 1.8× 98 0.1× 251 0.5× 307 0.9× 182 4.6k
Noemí Cárdenas‐Rodríguez Mexico 20 167 0.2× 555 0.6× 197 0.2× 647 1.2× 203 0.6× 72 1.9k
Brendan T. Griffin Ireland 36 413 0.4× 1.2k 1.3× 176 0.2× 64 0.1× 115 0.3× 104 3.7k
P. Uma Devi India 29 212 0.2× 779 0.9× 74 0.1× 581 1.1× 136 0.4× 152 3.1k
F.W.H.M. Merkus Netherlands 34 232 0.2× 846 0.9× 90 0.1× 75 0.1× 235 0.7× 78 3.1k
L J Marton United States 25 270 0.3× 1.6k 1.8× 115 0.1× 104 0.2× 85 0.3× 55 2.4k
Matthias Brandsch Germany 36 638 0.7× 1.6k 1.8× 60 0.1× 85 0.2× 203 0.6× 73 4.0k
Roger D. Hurst New Zealand 29 142 0.1× 1.1k 1.2× 76 0.1× 649 1.2× 174 0.5× 95 3.6k
G. Mellows United Kingdom 21 121 0.1× 763 0.8× 154 0.2× 146 0.3× 91 0.3× 40 1.8k

Countries citing papers authored by Boris Yagen

Since Specialization
Citations

This map shows the geographic impact of Boris Yagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Yagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Yagen more than expected).

Fields of papers citing papers by Boris Yagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Yagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Yagen. The network helps show where Boris Yagen may publish in the future.

Co-authorship network of co-authors of Boris Yagen

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Yagen. A scholar is included among the top collaborators of Boris Yagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Yagen. Boris Yagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neuman, Manuela G., Radu M. Nanau, Tawfeeq Shekh‐Ahmad, Boris Yagen, & Meir Bialer. (2013). Valproic acid derivatives signal for apoptosis and repair in vitro. Clinical Biochemistry. 46(15). 1532–1537. 6 indexed citations
2.
Chang, Pishan, Oliver Hoeller, Jakob A. Shimshoni, et al.. (2011). The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium. Disease Models & Mechanisms. 5(1). 115–124. 66 indexed citations
3.
4.
5.
Okada, Akinobu, et al.. (2009). Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Birth Defects Research Part B Developmental and Reproductive Toxicology. 86(5). 394–401. 5 indexed citations
6.
Bialer, Meir & Boris Yagen. (2007). Valproic Acid: Second Generation. Neurotherapeutics. 4(1). 130–137. 119 indexed citations
7.
8.
Shimshoni, Jakob A., et al.. (2005). Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain. British Journal of Pharmacology. 146(2). 198–208. 57 indexed citations
9.
Isoherranen, Nina, Boris Yagen, & Meir Bialer. (2003). New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?. Current Opinion in Neurology. 16(2). 203–211. 62 indexed citations
10.
Isoherranen, Nina, H. Steve White, Richard H. Finnell, et al.. (2002). Anticonvulsant Profile and Teratogenicity of N‐methyl‐tetramethylcyclopropyl Carboxamide: A New Antiepileptic Drug. Epilepsia. 43(2). 115–126. 25 indexed citations
11.
Gliko-Kabir, Irit, Boris Yagen, Adel Penhasi, & Abraham Rubinstein. (2000). Phosphated crosslinked guar for colon-specific drug delivery. Journal of Controlled Release. 63(1-2). 121–127. 112 indexed citations
12.
Spiegelstein, Ofer, Deanna L. Kroetz, René H. Levy, et al.. (2000). Structure Activity Relationship of Human Microsomal Epoxide Hydrolase Inhibition by Amide and Acid Analogues of Valproic Acid. Pharmaceutical Research. 17(2). 216–221. 12 indexed citations
13.
Spiegelstein, Ofer, Meir Bialer, Matthias Radatz, H. Nau, & Boris Yagen. (1999). Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid. Chirality. 11(8). 645–650. 14 indexed citations
14.
Gliko-Kabir, Irit, Boris Yagen, Adel Penhasi, & Abraham Rubinstein. (1998). Low Swelling, Crosslinked Guar and Its Potential Use as Colon-Specific Drug Carrier. Pharmaceutical Research. 15(7). 1019–1025. 83 indexed citations
15.
Radatz, Matthias, et al.. (1998). Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Research. 30(1). 41–48. 55 indexed citations
16.
Barel, Shimon, Boris Yagen, Volker Schurig, et al.. (1997). Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy*. Clinical Pharmacology & Therapeutics. 61(4). 442–449. 36 indexed citations
17.
Yagen, Boris & Meir Bialer. (1993). Metabolism and Pharmacokinetics of T-2 Toxin and Related Trichothecenes. Drug Metabolism Reviews. 25(3). 281–323. 35 indexed citations
18.
Yagen, Boris, et al.. (1989). Aflatoxin B1S: Revised Structure for the Sodium Sulfonate Formed by Destruction of Aflatoxin B1 with Sodium Bisulfite,. Journal of Food Protection. 52(8). 574–577. 10 indexed citations
19.
Bergmann, Felix, Dov Soffer, & Boris Yagen. (1988). Cerebral toxicity of the trichothecene toxin T-2, of the products of its hydrolysis and of some related toxins. Toxicon. 26(10). 923–930. 15 indexed citations
20.
Sintov, Amnon, Meir Bialer, & Boris Yagen. (1987). Pharmacokinetics of T-2 tetraol, a urinary metabolite of the trichothecene mycotoxin, T-2 toxin, in dog. Xenobiotica. 17(8). 941–950. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Grove Breakdown of academic impact, for papers by Fátima Martel Breakdown of academic impact, for papers by Noemí Cárdenas‐Rodríguez Breakdown of academic impact, for papers by Brendan T. Griffin Breakdown of academic impact, for papers by P. Uma Devi Breakdown of academic impact, for papers by F.W.H.M. Merkus Breakdown of academic impact, for papers by L J Marton Breakdown of academic impact, for papers by Matthias Brandsch Breakdown of academic impact, for papers by Roger D. Hurst Breakdown of academic impact, for papers by G. Mellows
Rankless by CCL
2026